{
    "2020-05-01": [
        [
            {
                "time": "",
                "original_text": "【太平洋医药】金域医学点评：拟定增引进优质战投，全方位提升公司竞争力",
                "features": {
                    "keywords": [
                        "金域医学",
                        "定增",
                        "优质战投",
                        "竞争力"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【太平洋医药】金域医学19年&20Q1点评：盈利能力持续提升，新冠核酸检测业绩弹性大",
                "features": {
                    "keywords": [
                        "金域医学",
                        "盈利能力",
                        "新冠核酸检测",
                        "业绩弹性"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}